Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

US Supreme Court turns down Sanofi appeal to revive EpiPen suit against Viatris

Ruchika Sharma18 April 2023 11:33 AM IST

Sanofi said in the lawsuit that it lost hundreds of millions of dollars in sales in the USD 1 billion-plus U.S. epinephrine auto-injector market due...

Moderna, Merck cancer vaccine plus Keytruda delays skin cancer return

Ruchika Sharma17 April 2023 3:59 PM IST

The vaccine is custom-built based on an analysis of a patient's tumors after surgical removal.

Expanded age indication for GSK’s AREXVY

GSK oral antibiotic drug to treat uncomplicated urinary tract infections meets main goals in late stage trials

Ruchika Sharma17 April 2023 2:39 PM IST

The drug, if approved, could become the first new type of antibiotic, which is critically important for countering drug-resistant infections, to treat...

Indian standards of drug regulation should be on par with global standards, recommends NITI Aayog

Ruchika Sharma17 April 2023 1:30 PM IST

Besides, in the revised draft of the bill, the Centre has proposed that the apex regulatory body, CDSCO, will be empowered to regulate the manufacture...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck to acquire Prometheus Biosciences for USD 11 billion

Ruchika Sharma17 April 2023 12:30 PM IST

Rahway: Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. have announced that the companies have entered into...

Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection

Zydus Lifesciences bags USFDA okay for Isoproterenol Hydrochloride Injection

Ruchika Sharma17 April 2023 11:29 AM IST

Ahmedabad: Drugmaker, Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to...

Bayer Chairman Norbert Winkeljohann wins backing from major shareholder advisory firms

Ruchika Sharma16 April 2023 1:00 PM IST

Frankfurt: Bayer Chairman Norbert Winkeljohann has won backing for his re-election from a pair of major shareholder advisory firms despite criticism...

Novo Nordisk Projects Oral Weight-Loss Pills to Take One-Third of GLP-1 Market by 2030

Novo Nordisk raises full-year forecast on GLP-1 drug sales

Ruchika Sharma16 April 2023 10:00 AM IST

The guidance upgrade also partly reflected higher expected sales in the U.S. of its Ozempic diabetes drug, which is based on the same active...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

Pfizer signs strategic cooperation pact with Sinopharm

Ruchika Sharma16 April 2023 9:00 AM IST

United States: Pfizer said on Thursday it has signed a strategic cooperation agreement with China's Sinopharm Group, and plans to seek approval to...

FNB Head and Neck Oncology: Check Out NBE Released Curriculum

Ruchika Sharma15 April 2023 2:00 PM IST

The National Board of Examinations (NBE) has released the curriculum for FNB Head and Neck Oncology.I. INTRODUCTION (BACKGROUND) Head and neck...

Novavax cut USD 50 million in costs, plans to slash more: CEO

Ruchika Sharma15 April 2023 2:00 PM IST

United States: Novavax Inc cut about $50 million in costs in the first quarter of 2023 and plans to slash more, Chief Executive John Jacobs said in an...

CDSCO Panel Directs Abbott to Incorporate New Safety, Follow-up Measures in Clarithromycin Study

USFDA clears reader for Abbott FreeStyle Libre 3 system

Ruchika Sharma15 April 2023 12:06 PM IST

The reader uses a rechargeable lithium-ion battery, which is commonly found in many other electronic devices like mobile phones.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok